Protagonist Therapeutics CEO Dinesh V. Patel to Speak at Multiple Investment Bank Conferences in March 2026

Reuters
02/24
Protagonist <a href="https://laohu8.com/S/LENZ">Therapeutics</a> CEO Dinesh V. Patel to Speak at Multiple Investment Bank Conferences in March 2026

Protagonist Therapeutics Inc. said President and CEO Dinesh V. Patel will participate in multiple investment bank conferences in March 2026: TD Cowen 46th Annual Health Care Conference (fireside chat on March 3, 2026, 11:50 a.m. ET; webcast https://event.summitcast.com/view/9z5g2VrV6e6rbCqQgDRoHA/6QuKhqDYvNSrPH8co9v5gd), Leerink Global Healthcare Conference (fireside chat on March 9, 2026, 4:20 p.m. ET; webcast https://event.summitcast.com/view/mT9poctHDNthc6b89WqVjf/K8FdPptAY5cyfndeY9RPP9), Jefferies Biotech on the Beach Summit (one-on-one meetings on March 10, 2026), Citizens Life Sciences Conference (fireside chat on March 11, 2026, 1:05 p.m. ET; webcast https://event.summitcast.com/view/BuMiPNPtyHKimMF6k4AFMd/UWj58vHDxUk6PseGJr4ebs), and Barclays 28th Annual Global Healthcare Conference (fireside chat on March 12, 2026, 11:30 a.m. ET; webcast https://cc.webcasts.com/barc002/031026a_js/?entity=30_ESKWJT8). Presentation replays will be available on the company’s Investor Relations Events and Presentations webpage: https://pr.report/iywa.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Protagonist Therapeutics Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202602240730ACCESSWRNAPR_____1140403) on February 24, 2026, and is solely responsible for the information contained therein.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10